Navigation Links
IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
Date:5/22/2012

e subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contacts:

IntelliCell BioSciences, Inc.
Rubenstein Investor Relations
Contact: Tim Clemensen
Email Contact: TClemensen@rubensteinir.com
(212) 843-9337  

University of Florida
College of Engineering
Helen Goh
Email Contact: hgoh@eng.ufl.edu


'/>"/>
SOURCE IntelliCell BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
2. IntelliCell BioSciences Expands Management Team
3. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
4. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
5. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
6. Milestone Biosciences, LLC Further Strengthens Executive Management Team
7. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
8. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
9. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
10. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
11. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... RARITAN, N.J. , June 1, ... announced data from the Phase 3 multicenter study ... survival (PFS) with trabectedin (YONDELIS ® ) compared ... or leiomyosarcoma (LMS) previously treated with an anthracycline ... is the largest randomized Phase 3 study ever ...
(Date:6/1/2015)... 2015 About Bio-alcohols Bio-alcohols ... or cellulose. Bio-alcohols are primarily used in the transportation ... replacement for gasoline in cars. Technavio,s analysts forecast the ... 9 percent over the period 2014-2019. ... be segmented into five: transportation, infrastructure, medical, and others. ...
(Date:6/1/2015)... , June 1, 2015  Novartis is highlighting ... of CTL019, an investigational chimeric antigen receptor (CAR) ... the treatment of specific types of hard-to-treat non-Hodgkin ... the University of Pennsylvania,s Perelman School of Medicine ... diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma ...
(Date:6/1/2015)... 2015  The Val Skinner Foundation is partnering with ... for high school students focused on cancer genetics. Skinner ... LIFE Event (LPGA Pros in the Fight to Eradicate ... West Caldwell, N.J. ... more than $500,000 on Monday, bringing the foundation,s 16-year ...
Breaking Biology Technology:Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6Global Bio-alcohols Market 2015-2019 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Val Skinner Foundation Announces Partnership With Discovery Education 2
... FULLERTON, Calif., Dec. 28 Beckman Coulter,Inc. ... manufacturer, and marketer of,products that simplify, automate, ... Scott Garrett, Beckman Coulter,s president and chief,executive ... Conference on,Tuesday, January 8, 2008, at 6:00 ...
... Hold Loramyc(R) ... Zensana(TM) Reformulation Complete, Resubmission ... Par,Pharmaceutical Companies, Inc. (NYSE: PRX ) ... its three, in-licensed, proprietary pipeline,products: pafuramidine, Loramyc(R) (miconazole ...
... Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer ... Tim Hansen will be,retiring as Chief Executive Officer ... http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ), Tim Hansen was ... of,the Company by the Board of Directors in ...
Cached Biology Technology:Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 2Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 3Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 4Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 5Imaging Diagnostic Systems CEO Announces Retirement 2Imaging Diagnostic Systems CEO Announces Retirement 3
(Date:6/1/2015)... June 1, 2015 According ... Biometrics Market by Application (Government, Military & Defense, ... Immigration, and Security), Technology (Face Recognition, Fingerprint Recognition, ... Vein Recognition, and Others), Function (Contact and Non-Contact) ... Europe , APAC, Row) - ...
(Date:5/27/2015)... CLEVELAND , May 27, 2015 /PRNewswire/ ... in medication safety systems and image documentation ... provider of comprehensive, technologically-advanced automation solutions, is ... art integration. The Codonics® Safe Label System® ... used in conjunction with the Omnicell Anesthesia ...
(Date:5/22/2015)... May 22, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... will be ending its promotional pricing and making the Wocket ... Laurence Savin , Head of Marketing said, "We,ve extended ... until the end of May. To get your wocket at ... we open the store on June 1, you,ll receive a ...
Breaking Biology News(10 mins):Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... Rockville, Md., August 26, 2010 Recent incidents ... pet food with the industrial chemical melamine revealed the ... and global food industry for determining protein content in ... methods is the subject of a new paper published ...
... next generation of neutron research at Indiana University Bloomington ... Institute for Standards and Technology. A recently awarded NIST ... five years to support cooperative research activities between the ... NIST,s National Center for Neutron Research, located in Gaithersburg, ...
... million grant from the National Institutes of Health ... translate new scientific findings and technological developments into ... designates Nationwide Children,s Hospital as a Paul D. ... three national award recipients in 2010. ...
Cached Biology News:New paper examines approaches to measuring protein in foods in context of deadly adulterations 2New paper examines approaches to measuring protein in foods in context of deadly adulterations 3New paper examines approaches to measuring protein in foods in context of deadly adulterations 4IU physics facility awarded $5 million for cooperative neutron research 2$7 million grant designates Nationwide Children's as Wellstone Center 2
... agarose-digesting enzyme isolated from Pseudomonas atlantica. ... in agarose producing carbohydrate molecules that ... carbohydrate molecules will not interfere with ... Gelzyme enzyme can be used for ...
... contains the cellular components necessary for protein ... and termination factors) but has not been ... used primarily for the isolation of these ... endogenous globin mRNA. Untreated Lysate is prepared ...
...
...
Biology Products: